Skip to content

Clinical trials

Alzheimer Disease trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Norway Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20081
20102
20111
20121
20132
20142
20151
20162
20173
20183
20195
20201
20212
20221
20234
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting9
Unknown status5
Active, not recruiting3
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital5
GlaxoSmithKline4
Helse Stavanger HF3
Norwegian Centre for Ageing and Health3
Norwegian University of Science and Technology3
University Hospital of North Norway3
University of Bergen3
Haukeland University Hospital2
Novartis Pharmaceuticals2
Oslo Metropolitan University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease43
Dementia13
Cognitive Dysfunction6
Brain Diseases3
Central Nervous System Diseases3
Dementia, Vascular3
Lewy Body Disease3
Nervous System Diseases3
Neurodegenerative Diseases3
Low Back Pain2

Trials

Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.